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structures in cellular physiology, pathology and therapyMembranes form selective barriers that separate, communicate and
deﬁne cells and their internal organelles, and they also receive and
propagate important signals that control cellular behavior. It is conven-
tional wisdom thatmost of the activity of a cell occurs within or around
membranes, and in this context, the functions of membranes do not de-
pend exclusively on the particular proteins that they contain, but rather,
they also depend on lipid composition and the lipid–protein structures
of membranes. These features of membranes both inﬂuence and partic-
ipate in the speciﬁc functions associated with different cells and the
overall control of a cell's physiology.
Importantly, alterations to the membranes of a cell may be involved
in various pathological processes. In this respect, interventions aimed at
regulating membrane composition, such as the replacement of
damaged phospholipids or the regulation of the membrane lipid com-
position, constitute an innovative form of treatment (lipid replacement
therapy or membrane lipid therapy). This special issue of BBA
Biomembranes aims to reﬂect the current status of this ﬁeld, placing
particular attention on the most recent advances in membrane
structure, composition and dynamics, especially membrane lipids, as
well as their modiﬁcations by therapeutic intervention. As such, this
issuewill be an important contribution to aﬁeld that is of utmost impor-
tance in biology and medicine.
Our knowledge of membrane structure has been acquired over
approximately the last century, developing from the initial discovery
that cell membranes contained lipids that could account for some of
their biophysical properties. It was almost 90 years ago that Gorter
and Grendel ﬁrst proposed that cell membranes were formed by a
lipid bilayer [1]. Subsequently, Davson, Danielli and Robertson
proposed trilayer membrane models that contemplated a complex
organization of membranes, with protein layers surrounding a lipid
bilayer [2,3]. An alternative membrane structure was also proposed
based on repeating lipoprotein subunits without a supporting lipid
bilayer matrix [4,5]. These models represented the ﬁrst approaches
that considered membrane structure and function from a new
perspective, although they still did not take into account membrane
dynamics. The ﬁrst model to consider the mobility of membrane
components in the plane of the membrane, the ﬂuid mosaic mem-
brane model, depicted biological membranes as a ﬂuid bilayer of
phospholipids into which mobile globular integral membrane pro-
teins and glycoproteins were intercalated [6]. This model contem-
plated dynamic changes in the organization and mobility of lipids
and integral and peripheral membrane proteins. Indeed, this model
is still valid, especially at the nano-scale level, if we accept certain
modiﬁcations, and it still constitutes the basic platform for manyhttp://dx.doi.org/10.1016/j.bbamem.2014.03.008
0005-2736/© 2014 Elsevier B.V. All rights reserved.new concepts related to the structure and function of biological
membranes.
The plasma membrane's relationship with the cytoskeleton and the
presence of membrane microdomains that deﬁne speciﬁc “plasma
membrane compartments” were initially described in the 1970s [7–9].
Furthermore, during the 1980s the importance of the lipid environment
in the function of transmembrane proteins began to be deciphered
[10–12]. By the 1990s, the roles of membrane lipid composition and
structure and how they inﬂuenced the localization,mobility and activity
of relevant peripheral membrane proteins, such as G proteins and PKC,
were revealed, highlighting the importance of membrane structure and
dynamics in the control of cellular signaling [13–15].
More recently, the physical properties ofmembranes that determine
their structure and function have become an important area of research
[16,17]. In addition, theﬁnding that some lipid alterations are associated
with cellular pathologies is a further indication that membranes are
more than just a physical boundary deﬁning cells and organelles. Signif-
icantly, the expansion in our understanding of membrane structure and
function has enabled nutraceutical and pharmaceutical interventions to
be developed that target certain membrane components, such as the
lipid bilayer [18,19].
This special issue contains a number of reviews that will provide the
reader with an insight into our current understanding of cellular
membranes, especially membrane lipid structures, and functions and
their potential therapeutic manipulations. . To begin with, two authori-
tative opinions and updates of the ﬂuid mosaic model of membrane
structure have been contributed by Garth Nicolson and Félix Goñi, and
a further three reviews deal with speciﬁc issues related to membrane
lipid composition. Dennis E. Vance has reviewed the phosphatidyletha-
nolamine N-methyl transferases and how they inﬂuence the physiolog-
ical membrane lipid composition, as well as their participation in
pathological alterations of the membrane. In addition, Guschina et al.
have addressed important aspects of lipid biosynthesis in plants, while
D'Souza and Epand highlighted the roles of phosphatidylinositol mole-
cules with speciﬁc fatty acyl moieties. The studies by Ibarguren et al.,
Piotto et al., and Tsai et al., each focus on speciﬁc structural aspects of
the lipid bilayer, such as the effect of fatty acids on themembrane struc-
ture and the role of lipids in themulti-step process of membrane fusion.
Protein–lipid interactions have crucial effects on the function of
membranes, and in this context, Philip Yeagle has reviewed the speciﬁc
interactions of themost importantmembrane lipidswith awide variety
of membrane proteins. The article by López-Rodriguez and Pérez-Gil
highlights what is currently known about pulmonary surfactants,
protein–lipid complexeswith relevant pathophysiological and therapeutic
1450 Prefaceimplications. Poveda et al., and Corbalán-García and Gomez-Fernandez
each summarize the interactions between lipids and the integral protein
channel, KcsA, and the peripheral protein kinase C (PKC), respectively.
The physiological role of membrane lipids in cells as well as their
participation in pathological conditions and their therapeutic potential,
is the focus of the last section of this special issue. Reuevn and collabo-
rators have reviewed the interactions of the Toll-like receptor trans-
membrane domains in innate immune responses, and their impact in
cancer, Alzheimer's disease and other pathologies. Lladó et al. have
reviewed the role of sphingomyelin synthase and related genes in the
prognosis and therapy of a brain cancer (glioma). The article by Törok
et al. highlights the role of plasma membrane lipids as heat stress sen-
sors and the therapeutic applications of this knowledge. Moreover,
López et al. review the impact of olive oil intake (Mediterranean diet)
on themembrane lipid composition and its relevance for human health.
In their second contribution, both Piotto and collaborators, andNicolson
and Ash, review the molecular basis underlying lipid therapies,
assessing how they can regulate membrane composition, and thus con-
tribute to normalizing cellular function. Finally, Torres et al. review the
effect of hydroxydocosahexaenoic acid on membrane composition in
the mouse brain and its possible use and efﬁcacy in the treatment of
Alzheimer's disease.
Despite the variety of topics in this Special Issue, one signiﬁcant
feature is clear in all of the articles: they all describe the membrane
lipid bilayer as a dynamic and heterogeneous structure with activities
that go beyond their simple boundary functions.
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